Couragene

Private

New JerseyHealthcare & Life Scienceshttps://www.couragene.com/

Last Round

Grant

Sep 19, 2024

Total Funding Raised

$42.94M

Company Overview

Couragene is a biotechnology company that develops gene and biologic therapies using its proprietary Stimuli-responsive Traceless Engineering Platform (STEP) for the delivery of genetic medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

non-viral deliverygene editinggenetic medicineCRISPR-Cas9in vivo deliverybiotechnologyneurogenetic disordersdrug deliverygene therapybiologic therapyoral drug deliverygenomic medicinebiotech startupdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Couragene Comps

Public and private peers based on sector, stage, and business model.

Couragene comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Couragene Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 19, 2024
Grant	Oct 10, 2023
Seed	Sep 6, 2022

View all Funding Rounds

Couragene Investors

Notable investors and investment history

Couragene investors
Investor	Rounds
Hi2 Global	Seed
Foothill Ventures	Seed
National Institute of Neurological Disorders and Stroke	Grant

View all Investors

Couragene Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Couragene Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Couragene's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey

Employee Range6

Year Founded2022

Last FundingSep 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.